Mary Jane Zimarowski, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Diseases | 4 | 2015 | 1094 | 0.780 |
Why?
|
| Skin | 5 | 2017 | 4484 | 0.600 |
Why?
|
| Vulvar Diseases | 1 | 2015 | 64 | 0.480 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2013 | 75 | 0.410 |
Why?
|
| Eosinophils | 2 | 2017 | 950 | 0.390 |
Why?
|
| Aminoquinolines | 1 | 2011 | 107 | 0.370 |
Why?
|
| Hair Diseases | 1 | 2011 | 72 | 0.350 |
Why?
|
| Measles | 1 | 2012 | 183 | 0.350 |
Why?
|
| Dermatitis | 1 | 2011 | 202 | 0.330 |
Why?
|
| Hair Follicle | 1 | 2011 | 211 | 0.320 |
Why?
|
| Epidermis | 1 | 2011 | 528 | 0.300 |
Why?
|
| Cicatrix | 1 | 2013 | 798 | 0.280 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 12973 | 0.160 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 2155 | 0.160 |
Why?
|
| Dapsone | 1 | 2017 | 56 | 0.150 |
Why?
|
| Skin Diseases, Parasitic | 1 | 2016 | 13 | 0.130 |
Why?
|
| Folliculitis | 1 | 2016 | 25 | 0.130 |
Why?
|
| Amebiasis | 1 | 2016 | 33 | 0.130 |
Why?
|
| Hyperpigmentation | 1 | 2017 | 117 | 0.130 |
Why?
|
| Leg Dermatoses | 1 | 2015 | 20 | 0.130 |
Why?
|
| Leg Ulcer | 1 | 2015 | 71 | 0.120 |
Why?
|
| Acyclovir | 1 | 2016 | 268 | 0.120 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2014 | 23 | 0.120 |
Why?
|
| Herpesvirus 3, Human | 1 | 2016 | 159 | 0.120 |
Why?
|
| Skin Neoplasms | 2 | 2011 | 5821 | 0.120 |
Why?
|
| Valine | 1 | 2016 | 408 | 0.110 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 978 | 0.110 |
Why?
|
| Herpes Zoster | 1 | 2016 | 253 | 0.110 |
Why?
|
| Alopecia | 1 | 2017 | 412 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 2016 | 376 | 0.100 |
Why?
|
| Hutchinson's Melanotic Freckle | 1 | 2011 | 25 | 0.100 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2016 | 575 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 1379 | 0.090 |
Why?
|
| Keratosis, Actinic | 1 | 2011 | 72 | 0.090 |
Why?
|
| Administration, Cutaneous | 1 | 2011 | 713 | 0.080 |
Why?
|
| Biopsy | 3 | 2016 | 6766 | 0.080 |
Why?
|
| Ascites | 1 | 2010 | 338 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 13642 | 0.080 |
Why?
|
| Gastric Bypass | 1 | 2015 | 818 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2010 | 807 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2010 | 711 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2013 | 2161 | 0.050 |
Why?
|
| Female | 8 | 2017 | 392705 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2016 | 1835 | 0.040 |
Why?
|
| Humans | 13 | 2017 | 761596 | 0.040 |
Why?
|
| Dermatitis, Contact | 1 | 2017 | 133 | 0.040 |
Why?
|
| Algorithms | 1 | 2017 | 14033 | 0.030 |
Why?
|
| Acanthamoeba castellanii | 1 | 2016 | 9 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 58984 | 0.030 |
Why?
|
| Aged | 5 | 2017 | 169310 | 0.030 |
Why?
|
| Thigh | 1 | 2016 | 241 | 0.030 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 178 | 0.030 |
Why?
|
| Sweating | 1 | 2014 | 155 | 0.030 |
Why?
|
| Arthralgia | 1 | 2014 | 461 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2016 | 858 | 0.020 |
Why?
|
| Ascitic Fluid | 1 | 2010 | 189 | 0.020 |
Why?
|
| Peritoneum | 1 | 2010 | 225 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 220921 | 0.020 |
Why?
|
| Syndrome | 1 | 2015 | 3267 | 0.020 |
Why?
|
| Male | 5 | 2016 | 360846 | 0.020 |
Why?
|
| Adult | 5 | 2016 | 221210 | 0.020 |
Why?
|
| Autopsy | 1 | 2010 | 1009 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 80647 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 1992 | 791 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 64685 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 3156 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1992 | 2209 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2016 | 3060 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11076 | 0.010 |
Why?
|
| Pain | 1 | 2015 | 5073 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 4915 | 0.010 |
Why?
|
| Recurrence | 1 | 2010 | 8466 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1992 | 21019 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1992 | 3597 | 0.000 |
Why?
|
| Age Factors | 1 | 1992 | 18399 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1992 | 9177 | 0.000 |
Why?
|